Dallas, Texas (PRWEB) September 20, 2013
These reports on Infectious Disease Testing Market 2014 Opportunities in the US, UK, Italy and Japan provides a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. These reports examines key US, UK, Italy and Japan market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, selorogy/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale:
These comprehensive reports will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Browse Reports Individually below:
Opportunities and Strategic Recommendations:
Infectious Diseases Analyzed in the Report:
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Market Segmentation Analysis:
° Hospitals
° Blood Banks
° Commercial/Private Laboratories
° Physician Offices/Group Practices
° Public Health Laboratories
Current and Emerging Products:
Technology Review:
Competitive Assessments:
Browse other reports by Venture Planning Group @ http://www.reportsnreports.com/publisher/venture-planning-group/ and Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.
About Us
ReportsnReports.com is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.
Read the full story at http://www.prweb.com/releases/2014-infectious-disease/testing-market-us-uk/prweb11144740.htm.
Source: PRWeb Copyright©2012 Vocus, Inc. All rights reserved |